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FTIRTranshydrogenase couples proton translocation across a bacterial or mitochondrial membrane to the redox
reaction between NAD(H) and NADP(H). Puriﬁed intact transhydrogenase from Escherichia coli was
prepared, and its His tag removed. The forward and reverse transhydrogenation reactions catalysed by the
enzyme were inhibited by certain metal ions but a “cyclic reaction” was stimulated. Of metal ions tested they
were effective in the order Pb2+NCu2+NZn2+=Cd2+NNi2+NCo2+. The results suggest that the metal ions
affect transhydrogenase by binding to a site in the proton-transfer pathway. Attenuated total-reﬂectance
Fourier-transform infrared difference spectroscopy indicated the involvement of His and Asp/Glu residues in
the Zn2+-binding site(s). A mutant in which βHis91 in the membrane-spanning domain of transhydrogenase
was replaced by Lys had enzyme activities resembling those of wild-type enzyme treated with Zn2+. Effects
of the metal ion on the mutant were much diminished but still evident. Signals in Zn2+-induced FTIR
difference spectra of the βHis91Lys mutant were also attributable to changes in His and Asp/Glu residues but
were much smaller than those in wild-type spectra. The results support the view that βHis91 and nearby Asp
or Glu residues participate in the proton-transfer pathway of transhydrogenase.© 2009 Elsevier B.V. All rights reserved.1. IntroductionTranshydrogenase is found in the inner membranes of animal
mitochondria and in the cytoplasmic membranes of bacteria. It
couples the transfer of hydride-ion equivalents between NAD(H) and
NADP(H) to the translocation of hydrogen ions across the membrane:
NADHþ NADPþ þ Hþp↔NADþ þ NADPH þ Hþn ð1Þ
where H+p and H+n refer to hydrogen ions in the p-phase and n-
phase, respectively (the outside and inside of the intact membrane
system). Hydride transfer proceeds directly between bound nucleo-
tides [1], and is stereospeciﬁc [2]: the pro-R hydrogen at C4 of the
dihydronicotinamide ring of NADH is transferred to C4 on the si face of
the nicotinamide ring of NADP+.
The physiological role of transhydrogenase varies amongst tissues
and species [3,4]. In some circumstances the enzyme provides NADPH
for biosynthesis reactions [5], and for the reduction of glutathione
needed to prevent oxidative damage to the cell [6–8]. In heart and
muscle mitochondria transhydrogenase may serve in the regulation of
the tricarboxylic acid cycle [9]. Recent experiments show that the
presence of a defective transhydrogenase gene in mice stressed by aetc); AcPdAD+, acetyl pyridine
).
r, Toyota Central R&D Labora-
apan.
ll rights reserved.high-fat diet leads to impairment of glucose-dependent insulin se-
cretion from pancreatic β-cells, suggesting links with human diabetes
[10,11].
Transhydrogenase has three components: dI, which binds NAD+
and NADH, and dIII, which binds NADP+ and NADPH, protrude from
the membrane, and dII spans the membrane. The high-resolution
structures of dI [12–14] and dIII [15–17], in isolation and in complex
[18–21], are currently available but not that of either the intact enzyme
or of dII. Amino acid-sequence analyses and biochemical data suggest
that, depending on species, transhydrogenase (a dimer) has 12–14
transmembrane helices per monomer [22–24]. For reviews of the
enzyme structure, see [25,26]. The hydride-transfer site at the interface
between dI and dIII is some30Å from themembrane-spanning dII, and
thus coupling with proton translocation must involve a long-distance
mechanical linkage. By analogy with the ATP synthase [27,28],
transhydrogenase can be viewed as a redox motor/generator (dI and
dIII) and a protonmotor/generator (dII) linkedbya common shaft. The
energy of the proton electrochemical gradient (Δp) can turn over the
proton motor, and hence operate the shaft to drive hydride transfer in
the redox generator. Alternatively, the enzyme can operate in reverse:
the energy of ΔEh between NAD+/NADH and NADP+/NADPH can
operate the shaft and generate a Δp. The subunit composition of
transhydrogenase is not consistent with rotary catalysis as described
for the ATP synthase [29], and the movements of the putative
driveshaft must be quite different (see [26]. Although much has been
learned about the redox motor/generator of transhydrogenase,
particularly in the light of the X-ray structures, there is less information
on the nature of the proton motor/generator. Extensive mutagenesis
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indicated some amino acid residues that are important for function but
it has been difﬁcult to establish the precise role of these residues.
Substitutions of the conserved His91 in the β subunit have been
studied in particular detail, leading to the suggestion that this residue
has a function in proton translocation [30–36].
The inhibition of proton-transfer steps by d-block metal ions such
as Zn2+ and Cd2+ has been described in studies on a number of
membrane proteins, including photosynthetic reaction centres
[37,38], cytochrome c oxidase [39–41], cytochrome bc1 complex [42],
NADH dehydrogenase [43] and voltage-gated proton channels [44]. In
the case of reaction centres [37], cytochrome oxidase [45] and
cytochrome bc1 complex [46], X-ray data has provided the structure
of Zn2+- and Cd2+-binding sites. His and Asp residues, and water
molecules, often provide ligands for the metal ions in accordance with
the expected chemistry [47]. The inhibitory metal-binding sites have
also been characterised in XAS experiments [48–50]. In all these
proteins the proton-transfer steps have an important functional role,
and investigations into the nature of metal-ion inhibition is leading to
a better understanding of the respective proton pathways.
In experiments with inside-out membrane vesicles from both
E. coli and Rhodospirillum rubrum, low concentrations of Zn2+ were
found to inhibit “reverse” transhydrogenation and, at neutral and high
pH, to stimulate “cyclic” transhydrogenation [51]. Reverse transhy-
drogenation was measured as the reduction of the NAD+ analogue,
acetylpyridine adenine dinucleotide (AcPdAD+), by NADPH, essen-
tially the reverse of Eq. (1). The reaction is known to drive proton
translocation through the protein and across the membrane [52,53].
Cyclic transhydrogenation, a wholly unphysiological reaction, is the
combined reduction of NADP+ by NADH and oxidation of NADPH by
AcPdAD+, when both take place without either the NADP+ or the
NADPH dissociating from the enzyme [54] — steps c and d in Fig. 1.
None of the steps in the cyclic reaction is accompanied by proton
translocation across the membrane [55]. Reverse and cyclic transhy-
drogenation share several intermediate steps and on this basis theFig. 1. Forward, reverse and cyclic reactions of transhydrogenase. E, E⁎ and E⁎⁎ represent
different conformational states of transhydrogenase. Forward transhydrogenation with
the physiological substrates, NADP+ and NADH, runs from top to bottom (dashed lines)
on the left of the ﬁgure. Reverse transhydrogenation with NADPH and AcPdAD+ runs
from bottom to top (dashed lines) on the right. Cyclic transhydrogenation is shown by
the dashed arrows in themiddle. Steps a–f are all referred to in the text. Step c subsumes
NADH binding, hydride transfer from bound NADH to bound NADP+, and NAD+ release.
Step d subsumes AcPdAD+ binding, hydride transfer from bound NADPH to bound
AcPdAD+, and AcPdADH release. Note that NAD+, NADH, AcPdAD+ and AcPdADH can
also bind to the E and E⁎ states of the enzyme but this does not signiﬁcantly affect the
reaction kinetics in the present context (see [26]). In the solubilised enzyme [H+p] and
[H+n] are identical.differential response to Zn2+ was attributed to an effect of the metal
ions on processes associated with NADP+ and NADPH binding and
release. It was suggested that these effects, in commonwith the effects
of the metal ions on reaction centres, bc1 complex and cytochrome
oxidase, might be a consequence of a block in transhydrogenase
proton transfer [51].
In this communication the metal-ion speciﬁcity of E. coli transhy-
drogenase inhibition is explored. A new preparation of the intact
enzyme with a cleavable His tag is described; the cleaved form has a
similar metal-ion sensitivity to that observed in membrane-bound
transhydrogenase. Attenuated total-reﬂectance Fourier-transform
infrared (ATR-FTIR) spectroscopy is used to characterise the site. The
properties of the metal-inhibited transhydrogenase are compared
with those of a mutant protein in which βHis91 is substituted with a
Lys residue. The model described in Fig. 1 is used to rationalise the
effects of Zn2+, pH and the effects of mutation on the transhydro-
genase mechanism.
2. Materials and methods
Cytoplasmic membrane vesicles for assays of transhydrogenase
activity were isolated either from cells of E. coli strain JM109 harbouring
the plasmid pSA2 [56], or from cells of E. coli strain BL21(DE3)Δpnt
harbouring the plasmid pNIC4 [57], and stored, as described [51].
A plasmid (pSI4) was constructed which encodes E. coli transhy-
drogenase with a 6-His tag, a Factor Xa protease site (Ile-Glu-Gly-Arg)
and a 3-Ala linker at the N-terminus of its α subunit. Two primers, 5′-
TTA-TAA-CAT-ATG-CAT-CAT-CAC-CAT-CAT-CAC-ATT-GAA-GGT-CGT-
GCG-GCA-GCC-ATG-CGA-ATT-GGC-ATA-CCA-AG-3′ and 5′-TCA-CGC-
CGC-GAA-TCA-CCA-CAT-C-′3 (Alta Bioscience) were used to generate
a 1.1 kb PCR product using pSA2 [56] as the template with BIO-X-ACT
DNA polymerase (Bioline). The product was ligated into pGEM T-Easy
(Promega) using the adenine overhangs in the PCR product that are
added by the polymerase, and the vector's compatible thymine
overhangs, to give the plasmid, pSI2. Preparations of pSI2 and of pET-
21a (Novagen) were digested with NdeI and XhoI. The ∼0.7 kb
fragment from pSI2 and the ∼5.4 kb fragment from pET21a were
puriﬁed and ligated to give pSI3, which was linearised with XhoI, and
treated with calf alkaline phosphatase. In parallel, pSA2 was digested
with XhoI, and the ∼2.8 kb fragment puriﬁed. This fragment and the
phosphatase-treated ∼6.05 kb fragment were ligated, and plasmid
with the correctly orientated insertion (pSI4) was identiﬁed by
restriction digest analysis. The entire transhydrogenase coding-region
was sequenced to conﬁrm there were no polymerase errors. When
required, pSI4 was transformed into competent cells of the transhy-
drogenase-deletion strain of E. coli BL21 (DE3) Δpnt [57].
A plasmid encoding a tagless βH91K transhydrogenase mutant
[31] (kindly made available by Dr. P.D. Bragg via Dr. J. Rydström), and
pSI4, were digested with both BstBI and AgeI. The ∼660 bp fragment
from the Bragg plasmid, and the ∼7.75 kb fragment from pSI4, were
ligated to give pSI5, which encodes βH91K transhydrogenase with a
cleavable His tag.
For protein puriﬁcation, E. coli BL21 (DE3) Δpnt cells harbouring
either pSI4 or pSI5 were grown, cultures were induced with isopropyl
thiogalactoside, and membranes were prepared in 50 mM Tris–HCl,
pH 8.0, 1 mM EDTA, 1 mM dithiothreitol, as described [57]; they were
supplemented with glycerol (50%) and stored at −80 °C. The wild-
type and βH91K proteins were puriﬁed at 4 °C from the respective
membranes by similar procedures but the former was assayed by
following reverse transhydrogenation, and the latter by following the
NADP+-dependent cyclic reaction (see below). Membranes (∼100 mg
protein) were thawed on ice and resuspended in 50 ml of 50 mM
sodium phosphate buffer, pH 7.5, 25 mM sodium cholate (Anatrace),
25 mM deoxycholate (Anatrace), 1 M KCl, 5 mM β-mercaptoethanol,
1 mM 4-(2-aminoethyl) benzenesulfonyl ﬂuoride hydrochloride
(AEBSF, Calbiochem) and one EDTA-free protease inhibitor tablet
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then centrifuged at 200,000 g for 1 h. The transhydrogenase proteins
were then puriﬁed from the supernatant fraction by Ni2+-afﬁnity
chromatography as described [57] except that Thesit was omitted
from the buffer solutions, and the proteinwas eluted from the column
with 20 mM Tris–HCl, pH 8.0, 0.7 M NaCl, 0.1% Anapoe35 (also called
Brij-35, Anatrace), 5 mM β-mercaptoethanol and 200 mM imidazole.
Fractions were selected according to purity on 10% SDS-PAGE (stained
with PAGE-Blue 83), protein content and transhydrogenation activity.
As expected, the protein ran as two bands on SDS-PAGE, ∼55 kDa (α)
and ∼45 kDa (β), and was adjudged to be typically N95% pure.
The pooled transhydrogenase fractions (∼22 ml) were concen-
trated to ∼1 ml by centrifugation at 2000 g through a 100 kDa cut-off
ﬁlter (Vivascience) and dialysed for 3 h against ∼250 volumes of
20 mM MES–KOH, pH 6.5, 50 mM NaCl, 3 mM CaCl2, 0.1% Anapoe35,
0.2 mM dithiothreitol at 4 °C. The solution was supplemented with 30
units factor Xa protease (Novagen) and 400 μg low molecular weight
heparin (Sigma-Aldrich), and then incubated at 8 °C for ∼24–36 h
until digestion was N95% complete as indicated by SDS-PAGE:
cleavage resulted in a size decrease of the α polypeptide consistent
with loss of the 1.1 kDa tag; it leaves three Ala residues preceeding the
N-terminal Met of the wild-type protein. Further protease activity was
then inhibited by addition of 1 mM AEBSF. The solution was passed
through a 0.2 μm ﬁlter, and concentrated to a volume of 0.2 ml by
centrifugation at 2000 g through a 100 kDa cut-off ﬁlter before
removing the cleaved His tag and the factor Xa protease by gel
ﬁltration. A Superose 6 10/300 column (GE Healthcare) was
equilibrated with 50 mM HEPES–KOH, pH 7.5, 0.2 M NaCl and 0.05%
Anapoe35 at 4 °C; this buffer was pre-treated with Chelex resin (Bio-
Rad) to remove contamination by metal ions according to the
manufacturer's instructions. The transhydrogenase solution was
applied to the column which was then developed in the same buffer.
Previous calibration of the column with standard proteins ensured
that transhydrogenase fractions (Mr ∼670 kDa in Anapoe35 micelles)
were uncontaminated by protease (43 kDa). Active fractions were
pooled (2–4 mg protein in ∼6.0 ml), supplemented with 25% glycerol,
and stored in aliquots at −20 °C.
Liposomes inlaid with transhydrogenase were prepared using egg-
yolk phospholipids by a detergent dialysis procedure [58,59].
Phosphatidyl choline (12 mg), phosphatidyl ethanolamine (6 mg),
phosphatidic acid (2 mg) – all from Lipid Products – in chloroform/
methanol (1/7, v/v) solution were mixed with cholesterol (7 mg) –
Sigma-Aldrich – in chloroform/methanol (2/1, v/v) solution, and
dried in a rotary evaporator at 20 °C at full vacuum. The lipids were re-
dissolved in 3ml diethyl ether and dried again, ﬁrst at ∼350mmHg to
a ﬁlm, and then for 30 min at full vacuum. They were resuspended in
2.8 ml of 20 mM HEPES, pH 7.2, 50 mM KCl and 2 mM MgCl2 (“REC
buffer”) and treated at 50 °C in a water-bath sonicator (Branson 1210)
for approximately 30 min. During this time the milky-white suspen-
sion became less turbid. The resulting liposomes were solubilised by
adding octylglucoside (Calbiochem) to 125mM, and further sonicated
to clarity before cooling slowly to 4 °C. Puriﬁed transhydrogenase
shorn of its His tag (200 μg) was diluted 2-fold with REC buffer
supplemented with 0.25 mM DTT and 25 mM octylglucoside, spin
concentrated to 0.25 ml, and added to the lipid solution. REC buffer
supplemented with 125 mM octylglucoside (1.0 ml) was added, and
the mixture was incubated with gentle agitation at 4 °C for 4 h. It was
then dialysed twice for 3 h at 4 °C against 1 L of REC buffer that had
been pre-treated with Chelex resin. The proteoliposome suspension
was diluted ∼2.5 fold in REC buffer, and centrifuged at 15000 g for
15 min at 3 °C. The supernatant was re-centrifuged at 100,000 g and
3 °C for 1.5 h to pellet the preferred fraction of the proteoliposomes.
The pellet was resuspended in 200 μl, and then made up to ∼9 ml,
with REC buffer. The proteoliposomes were stable for N4 days when
stored at 4 °C, and for N2 weeks at−20 °C when supplemented with
25% glycerol. Liposomes containing trapped Fluo-Zin3 (MolecularProbes) were made using a similar procedure except that, following
octylglucoside solubilisation, ﬂuorophore (ﬁnal concentration 1 μM)
was added to the phospholipids (10 mg ml−1) instead of protein. At
the end of the preparation, ﬂuorophore in the external aqueous phase
was removed by passage down 2×5 ml HiTrap desalting columns (GE
healthcare) connected in series and pre-equilibrated with REC buffer.
Care was taken to minimise the exposure of the ﬂuorophore to light
throughout the preparation.
Protein concentrations of membrane preparations, and of puriﬁed
protein, were determined using the bicinchoninic acid assay [60].
They are expressed as mol of transhydrogenase αβ dimer (otherwise
known as the “dI–dII–dIII monomer”).
Reverse transhydrogenation was assayed by following the
absorbance change due to the reduction of AcPdAD+ by NADPH at
375 nm in the conditions described in the ﬁgure legends, using an
extinction coefﬁcient of 6.1 mM−1 cm−1 [61] with a Kontron Uvikon
923. The deﬁnition of the term, “cyclic transhydrogenation”, has
become blurred in the literature; we shall deﬁne it here as the
consecutive reduction of enzyme-bound NADP+ by NADH, and
oxidation of enzyme-bound NADPH by AcPdAD+. By this deﬁnition,
cyclic transhydrogenation takes place without either the NADP+ or
NADPH leaving the enzyme (steps c plus d in Fig. 1). “NADP+-
dependent cyclic transhydrogenation” was measured as the reduc-
tion of AcPdAD+byNADH in the presence of addedNADP+; note that,
when NADPH can dissociate from the enzyme, some forward
transhydrogenation (net reduction of NADP+byNADH) accompanies
this reaction— see Fig. 1; however, it does not lead to any absorbance
change, and is therefore not detected in the assay [55]. In some
experiments the reduction of AcPdAD+ by a combination of NADH
and NADPH (sometimes called “NADPH-dependent cyclic transhy-
drogenation”) was measured. At low pH most of this AcPdAD+
reduction takes place via the cyclic reaction (reducing equivalents
come fromNADH) but, when NADP+ can dissociate from the enzyme
(eg at higher pH), some is due to a reverse transhydrogenation
(reducing equivalents come fromNADPH), and this contributes to the
absorbance change at 375 nm [54,55].
Rates of forward transhydrogenation were measured in a dis-
continuous assay in the buffer described in the ﬁgure legends.
Samples were removed at 0, 1, 2 and 3 min after initiating the reaction
with NADH, and quenched with an equal volume of 1 M KOH in 50%
v/v ethanol at 20 °C. After 10–20 min at 20 °C each extract was
adjusted to pH 8.0 by addition of 2 ml 1 M MOPS, pH 6.0. The NADPH
concentration was then determined ﬂuorimetrically with glutathione
reductase, as described [62], in an assay based on that developed [63].
Forward, reverse and cyclic rates are all expressed per mol of the
transhydrogenase αβ dimer (dI–dII–dIII monomer).
The content of bound NADP+ in puriﬁed transhydrogenase pre-
parations was measured after acid extraction, and of NADPH after
alkali extraction, using the method described [63], as modiﬁed [62].
Fluorescence assays of extracted nucleotides and of FluoZin-3 in
liposomes were carried out on a Spex FluoroMax.
For ATR-FTIR measurements, ﬁlms of puriﬁed, de-tagged
transhydrogenase were prepared as described for the His-tagged
enzyme [57] but with two minor modiﬁcations. First, phosphate
buffer (which has a high afﬁnity for metal ions) was replaced
throughout with 10 mM HEPES–KOH, pH 7.5. Second, the two
detergents, sodium cholate and octylglucoside, were each added to
the 200 μl transhydrogenase aliquot to give a ﬁnal concentration
of 0.2% w/v. This was incubated on ice for 30 min before dilution
with 3 ml of 10 mM HEPES–KOH, pH 7.5 and proceding with the
subsequent centrifugation steps. Poly-L-His ﬁlms for ATR-FTIR were
prepared as described [64]. ATR-FTIR spectra were recorded as
described [57].
ZnCl2, CdCl2, Pb(NO3)2, CuSO4, NiCl2, CoCl2, MnCl2 were obtained
from Fluka at the highest purity available. Contamination by other
metal ions is quoted by the manufacturers as b0.0005%. Deionised
Table 1
Effect of metal ions on transhydrogenation activities.
Krev0.5 (μM)a Kcyc0.5 (μM)b Maximal stimulation of cyclicb (%)
Pb2+ 1.5 2 479
Cu2+ 5 4 427
Zn2+ 9.5 29 410
Cd2+ 11 31 383
Ni2+ 25 35 215
Co2+ N200c N150d N30d
E. coli membranes (typically 14 μg protein, prepared from cells harbouring pSA2, see
Materials and methods) were suspended in 1.0 ml HEPES–NaOH, pH 7.2, 2 mMMgCl2 at
25 °C. In all experiments metal salts were added prior to the addition of nucleotides.
a Reverse transhydrogenationwasmeasured in the presence of 200 μMAcPdAD+ and
200 μM NADPH; Krev0.5 is the concentration of metal ion inhibiting the reaction by 50%.
b In NADP+-dependent cyclic transhydrogenation the membranes were incubated
for ∼30 s in the presence of 200 μMNADH and 50 μMNADP+ before addition of 200 μM
AcPdAD+. Rates weremeasured ∼5 s later. The maximal stimulation of the reactionwas
measured at the concentration of metal ion giving the highest rate; Kcyc0.5 is the
concentration of metal ion needed for half-maximal stimulation.
c At 200 μM Co2+ reverse transhydrogenation was 35% inhibited.
d At 150 μM Co2+ cyclic transhydrogenation was stimulated by 30%.
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3. Results
3.1. Metal-ion speciﬁcity
Using inside-out membranes of E. coli and R. rubrum it was shown
that Zn2+ and Cd2+ inhibit reverse transhydrogenation but, at neutral
and high pH, stimulate NADP+-dependent cyclic transhydrogenation
[51]. For the reverse reaction Zn2+ lowered both the Vmax and the
apparent Km for NADPH and AcPdAD+ [51]; because of its ping-pongFig. 2. The effect of Zn2+ on CHT-transhydrogenase activities. (A) Reverse transhydrogenatio
2 mMMgCl2 and 0.03% Anapoe35. The buffer was 50 mMMES–KOH, pH 6.2 (●), 50 mM HEP
each sample and then, 30 s later, 200 μM AcPdAD+ to initiate the reaction. The reaction ra
Conditions and buffers as in (A) but using 55 pmol CHT-transhydrogenase; NADH (200 μM) a
initiate the reaction. (C) Reduction of AcPdAD+ by NADPH plus NADH. Conditions and buf
(100 μM)were added to each sample and then, 30 s later, 200 μMAcPdAD+ to initiate the rea
suspended in 2.0 ml 50 mM HEPES, pH 7.2, 2 mMMgCl2 and 0.03% Anapoe35. NADP+ (200 μM
removed at 0, 1, 2 and 3 min, quenched with ethanolic KOH and assayed for NADPH as desc
3 min. The scale on the ordinates represents AcPdAD+ reduction in panels (A–C), and NADcharacter (Fig. 1), the cyclic reaction is subject to substrate inhibition
[65], and this complexity discourages useful steady-state kinetic
analysis of the metal-ion effect.
Table 1 summarises data on the speciﬁcity of the phenomenon
with a range of other metal ions in E. coli membranes. In addition to
Zn2+ and Cd2+, it was found that Pb2+, Cu2+, Ni2+ and Co2+ inhibited
reverse, and stimulated cyclic transhydrogenation; the order of
effectiveness was Pb2+NCu2+NZn2+=Cd2+NNi2+NCo2+. At least
for Pb2+, Cu2+, Zn2+ and Cd2+, the inhibitory effect of the metal ion
on reverse transhydrogenation (at a concentration equal to Krev0.5)
was fully reversed upon addition of 0.25 mM EDTA. Concentrations of
metal ions higher than those found to stimulate the cyclic reaction led
to inhibition but this effect was not studied further. Hg2+ did not
stimulate the cyclic reaction at any concentration but it inhibited the
reaction rather less (eg ∼20% at 2 μM metal ion) than it inhibited
reverse transhydrogenation (∼80% at 2 μM metal ion); this indicates
that Hg2+ has the same effect as the other metal ions but that there
are additional inhibitory site(s). Mn2+ and Ca2+ (up to 150 μM) had
no effect on either reverse or cyclic transhydrogenation.
3.2. The effect of metal ions on puriﬁed, detergent-dispersed
transhydrogenase
There was good evidence that observations on the effects of Zn2+
and Cd2+ on transhydrogenase reactions in E. coli and R. rubrum
vesicles were not distorted by other enzymes in the membranes that
use nicotinamide nucleotides [51]. However, to understand better the
nature of metal-ion inhibition, experiments on puriﬁed, detergent-
dispersed enzyme are required. The experiments described in ref [51],
and those above, were carried out with E. coli membranes isolated
from cells over-expressing transhydrogenase from the pSA2 plasmid;
this protein does not carry a His tag [56]. When the experiments weren. Puriﬁed CHT-transhydrogenase (50 pmol) was suspended in 1.0 ml buffer containing
ES–KOH, pH 7.2 (○) or 50 mM HEPES–KOH, pH 8.2 (▲). NADPH (200 μM) was added to
tes were measured after about 5 s. (B) NADP+-dependent cyclic transhydrogenation.
nd NADP+ (50 μM)were added to each sample and then, 30 s later, 200 μMAcPdAD+ to
fers as in (A) but using 45 pmol CHT-transhydrogenase; NADH (200 μM) and NADPH
ction. (D) Forward transhydrogenation. Puriﬁed CHT-transhydrogenase (330 pmol) was
) was added, followed by 200 μMNADH to initiate the reaction. Samples (0.5 ml) were
ribed in the Materials and methods. The reaction rates were approximately linear over
P+ reduction in panel (D). Temperature=25 °C.
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genase from the pNIC4 plasmid (this protein does carry an N-terminal
His tag on its α-subunit [57]), the results were different: ﬁrst, the
addition of Zn2+ led to much more potent inhibition of reverse
transhydrogenation (50% by 0.75 μM metal ion at pH 7.2); second,
Zn2+ inhibited the NADP+-dependent cyclic reaction at pH 6.2 (by
60% at 50 μM metal ion) and had no stimulatory effect at pH 7.2.
Since, on the one hand, the tag is important for efﬁcient and
reproducible puriﬁcation of the enzyme but, on the other, it masks
the distinctive effect of metal ions on NADP(H) dissociation, we
have prepared E. coli transhydrogenase with a cleavable His tag (see
Materials and methods). The tag was used to purify the protein by
Ni2+ chromatography and then removed by treatment with factor
Xa protease. The puriﬁed enzyme, shorn of its His tag, is designated
CHT (cleaved His tag) transhydrogenase. At pH 7.2 it catalysed reverse
transhydrogenation (mean rate=1212±53 mol AcPdAD+ reduced
mol−1 protein min−1 for 6 independent enzyme preparations)
and NADP+-dependent cyclic transhydrogenation (407±33 mol
AcPdAD+ reduced mol−1 protein min−1, 6 preparations). The rate
of forward transhydrogenation with physiological substrates (NADH
and NADP+), measured in a discontinuous assay (see Materials and
methods), was 110 and 85 mol AcPdAD+ reduced mol−1 protein
min−1 in two independent preparations. Thus, the CHT enzyme has
a comparable transhydrogenase activity to that of the His-tagged
protein (compare [57]).
As in membrane vesicles expressing untagged enzyme [51] Zn2+,
at pH 7.2, inhibited reverse transhydrogenation catalysed by puriﬁed
CHT protein (Fig. 2A), and stimulated NADP+-dependent cyclic
transhydrogenation (Fig. 2B). Similar concentrations of Zn2+ were
effective in the isolated protein and the membranes. Cd2+, Cu2+, Ni2+
and Pb2+ were also tested for their effects on CHT-transhydrogenase
at pH 7.2. The ﬁrst three inhibited the reverse reaction, and stimulated
NADP+-dependent cyclic, at similar concentrations to those found for
the membrane-bound enzyme expressed from pSA2 (data not
shown). Higher concentrations of Pb2+ (approximately 30 μM) were
required to achieve inhibition of reverse transhydrogenation and
stimulation of cyclic with CHT enzyme than with E. coli membrane
preparations. This was probably due to sequestration of the Pb2+ by
the Anapoe35 (Brij-35) used in the assay buffer for the solubilised
enzyme to enhance the rates of reaction (a device introduced by [52]
and see [66]): at lower concentrations of Anapoe35 in the assay buffer
the rates of transhydrogenationwere reduced but the concentration of
Pb2+ needed to affect the reaction was lowered towards that found to
be effective with the membrane-bound enzyme (data not shown).
The effects of Zn2+ on reverse transhydrogenation and on the
NADP+-dependent cyclic reaction catalysed by the CHT enzyme at
different pH values are shown in Fig. 2A and B, respectively. In the
absence of metal, the rate of reverse transhydrogenation is maximal at
pH 7.2 and falls off at higher and lower pH [34,54]. In Fig. 2A this is
reﬂected in the three rates recorded in the absence of Zn2+. The Zn2+-
concentration proﬁles show that the metal ion more potently
inhibited reverse transhydrogenation when the assay was performed
at high pH; the concentration of Zn2+ needed for half-maximal
inhibition was 19 μM at pH 6.2, 7 μM at pH 7.2 and 2.5 μM at pH 8.2.
This apparent competition between H+ and Zn2+ binding was also
evident in experiments in which the maximum rate of reverse
transhydrogenation was shifted to a lower pH in the presence of a
ﬁxed, low concentration of the metal ion (results not shown).
Experiments on the effects of Cd2+ and Cu2+ on the reverse reaction
established that these metal ions too were more potent inhibitors at
high pH: at 45 nM enzyme, half-maximal inhibition required 21 μM
Cd2+ at pH 6.2, 9 μM at pH 7.2 and 3 μM at pH 8.2; half-maximal
inhibition required 2.5 μM Cu2+ at pH 6.2, 0.8 μM at pH 7.2 and 0.4 μM
at pH 8.2 (results not shown).
In Fig. 2B the data points recorded in the absence of Zn2+ conﬁrm
earlier ﬁndings that the rate of theNADP+-dependent cyclic reaction ismaximal at around pH 6, and declines at higher pH values [34,35,54].
As in E. coli membranes, the addition of Zn2+ up to 100 μM had no
effect on the already-high rate of the cyclic reaction at pH 6.2.
Moreover, at elevatedpH (7.2 and8.2 in Fig. 2B),where the basal rate of
the cyclic reaction is lower, the addition of Zn2+ led to strong
stimulation — the rate at high Zn2+ concentration approached that
observed at pH 6.2±Zn2+.
At pH 6.2 transhydrogenase catalyses the rapid reduction of
AcPdAD+ when supplied with a combination of NADPH and NADH
[34,35,54]; the rate is approximately 2.5-times faster than the rate of
AcPdAD+ reduction by NADPH alone (see Fig. 2) and approximately
25-times faster than the rate of AcPdAD+ reduction by NADH alone. At
this pH AcPdAD+ reduction by NADPH plus NADH is dominated by the
cyclic reaction (with reducing equivalents coming from the NADH)
but it also has a small contribution from reverse transhydrogenation
(with reducing equivalents coming from the NADPH) [55]. Its rate
slows at higher pH as the contribution from the cyclic reaction
decreases. AcPdAD+ reduction by NADPH plus NADH catalysed by
CHT-transhydrogenase was stimulated by Zn2+ at pH 7.2 and 8.2
(Fig. 2C). The effective concentration rangewas similar to that causing
stimulation of the NADP+-dependent cyclic reaction (Fig. 2B). At pH
6.2 the effect of Zn2+ on AcPdAD+ reduction by the combination of
NADPH and NADH was rather complex; Fig. 2C shows that low
concentrations of Zn2+ led to partial inhibition but that the residual
rate was then resistant to higher concentrations of metal ion. This
might reﬂect the fact that there are two processes contributing to the
measured AcPdAD+ reduction. At pH 7.2, Cd2+, Co2+, Cu2+, Ni2+ and
Pb2+ all increased the rate of reduction of AcPdAD+ by the com-
bination of NADH and NADPH (data not shown). The effective
concentration of each metal ion needed for stimulation was
approximately similar to that required to stimulate NADP+-depen-
dent cyclic at the same pH, although again comparison was com-
plicated by the contribution from reverse transhydrogenation.
Membrane preparations and puriﬁed, detergent-dispersed pre-
parations of transhydrogenase catalyse very low rates of AcPdAD+
reduction by NADH even in the absence of added NADP+ or NADPH
[32,54,66,67] — and see [62,68]. Consistent with our earlier experi-
ments on other detergent-dispersed preparations of E. coli transhy-
drogenase [54,67], the rate of this reaction in CHT-transhydrogenase
at pH 6.2 and pH 7.2 was only 4–6% of that measured in the presence
of added NADP+. Some authors have found proportionately much
higher rates in other preparations (eg 59.5% in “washed membrane
vesicles” at low pH [32]). The nature of the reaction has been
controversial [32,54,66–68] but earlier explanations have now been
eliminated. On the basis of inhibitor experiments [66], that there is
only one hydride-transfer site per enzyme monomer [18], that the
pro-R hydride on C4N of NADH is transferred to the re-face of C4N of
AcPdAD+ [67], and that exhaustive removal of tightly bound NADP+
and NADPH from the wild-type enzyme does not eliminate the
reaction [67], only one viable explanation remains. It must be the
result of either AcPdAD+ or NADH entering the “wrong” nucleotide-
binding site – the NADP(H) binding site on dIII –with low afﬁnity, and
participating in an aberrant cyclic reaction in which the dIII-bound
AcPdAD+/NADH is alternately oxidised by AcPdAD+ and reduced by
NADH bound to dI (see also Ref. [68]). Although in our experiments
the reaction is very slow, and is therefore difﬁcult to measure even at
high protein concentrations, the reduction of AcPdAD+ by NADH in
the absence of added NADP(H) in the CHT enzyme was found to be
stimulated by Zn 2+. Stimulation was to approximately the same
extent, and required approximately the same concentrations of Zn2+,
as the equivalent reaction in the presence of added NADP+ (data not
shown).
The effect of Zn2+ on forward transhydrogenation, measured using
a discontinuous assay at pH 7.2, is shown in Fig. 2D. The metal ions
inhibited the reaction across the concentration range that was
effective in blocking reverse transhydrogenation.
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When CHT-transhydrogenase was pre-incubated for only a few
seconds with NADH and NADP+ in pH 7.2 buffer before addition of
AcPdAD+ to initiate the cyclic reaction, the formation of AcPdADH
began at a low rate and then accelerated over a period of ∼45 s
(Fig. 3A). However, when the pre-incubation with NADH and NADP+
was extended to about 60 s before the AcPdAD+ addition, the rate of
AcPdADH production immediately (within 5 s) reached its maximum
value (Fig. 3B). This suggests that a build-up of NADPH in solution –
generated during reduction of NADP+ by NADH, and not observed in
the measurement at 375 nm – is necessary before rapid turnover of
the cyclic reaction can begin. The measured rate of forward trans-
hydrogenation (see above) indicates that in these experiments about
3 μMNADPHwould have been generated in 30 s. This simple picture is
supported by the presence of the lag, (a) when CHT-transhydrogenase
was pre-mixed (for times up to 60 s) with NADH and AcPdAD+ in pH
7.2 buffer, and the cyclic reaction was then initiated by addition of
NADP+ (Fig. 3C), and (b) when the enzyme was pre-mixed (for times
up to 60 s) with NADP+ and AcPdAD+ in pH 7.2 buffer, and the
reactionwas initiated by addition of NADH (not shown). In each of the
two latter experiments there was no opportunity for the enzyme toFig. 3. A lag at the onset of transhydrogenation. (A) Puriﬁed CHT-transhydrogenase
(60 pmol) was suspended in 1.0 ml 50 mM HEPES–KOH, pH 7.2, 2 mMMgCl2 and 0.03%
Anapoe35 at 25 oC. NADH (200 μM) and NADP+ (50 μM) were added together, followed
15 s later by AcPdAD+ (200 μM). (B) As in experiment (A) except that the AcPdAD+was
added 60 s after the NADH/NADP+. (C) As in experiment (B) except that the reaction
was initiated with NADP+ 60 s after a combination of NADH and AcPdAD+. (D) As in
experiment (A) except that NADPH (200 μM) was added instead of NADP+. (E) As in
experiment (C) except that the HEPES was replaced by 50 mMMES–KOH, pH 6.2. (F) As
in experiment (C) except for the presence of 50 μM Zn2+. (G) As in experiment (C)
except that puriﬁed CHT-βH91K (75 pmol) was used instead of wild-type CHT enzyme.
The horizontal bar represents 30 s in all experiments. The vertical bar represents a
change of 0.1 A at 375 nm in experiments (A–D) and (F–G), and of 0.2 A in experiment
(E). Temperature=25 °C.reduce any NADP+ before the initiation of the cyclic (and forward)
reaction. There was no detectable lag during AcPdAD+ reduction by
the combination of NADPH and NADH regardless of which nucleotide
was added to initiate the reaction (eg Fig. 3D).
The lag was also evident when the experiments described above
were repeated in pH 8.2 buffer (data not shown). However, at pH 6.2 it
was abolished. Thus, when CHT-transhydrogenase was pre-mixed
with NADH and AcPdAD+ in pH 6.2 buffer, the cyclic reaction began
promptly at a high rate when subsequently initiated by an addition of
NADP+ (Fig. 3E). Furthermore, at pH 7.2 and 8.2, 50 μM Zn2+ com-
pletely abolished the lag; for example in the experiment shown in
Fig. 3F (pH 7.2) a high rate of AcPdAD+ reduction was established
immediately after the addition of NADP+ to enzyme pre-mixed with
NADH and AcPdAD+.
The lag observed with puriﬁed CHT-transhydrogenase was also
seen in E. coli membrane preparations under similar conditions (data
not shown) but to our knowledge has not been previously reported.
3.4. Inhibition by Zn2+ of reconstituted CHT-transhydrogenase
The ﬁnding that Zn2+modiﬁes the transhydrogenation reactions of
E. coli vesicles [51]might indicate that themetal-ion binding site in the
protein is located on the n-side of the membrane. However, E. coli can
express transport systems for Zn2+ [69], and the metal-ion im-
permeability of the membrane is therefore not assured. We explored
several procedures for incorporating puriﬁed CHT-transhydrogenase
into liposomes with a view to investigating the location of the metal-
ion binding site in the protein. An octylglucoside-dialysis procedure
(see Materials and methods) gave preparations with the best Δp
control: reverse transhydrogenation at pH7.2was stimulated routinely
by between 6.0- and 8.5-fold upon addition of an uncoupling agent
(carbonylcyanide-p-triﬂuoromethoxyphenyl hydrazone, 5 μM) to
these proteoliposomes, indicating that the membranes are imperme-
able to protons. It will be assumed in the following that, whilst the
transhydrogenase might insert into the membrane in two possible
orientations, nucleotide substrates are only accessible to those
proteins in which the dI/dIII components face outwards — only these
proteins will catalyse the transhydrogenase reaction. In a series of ex-
periments with the proteoliposomes at pH 7.2, it was found that Zn2+
inhibited reverse transhydrogenation and stimulated the NADP+-
dependent cyclic reaction at similar concentrations to those that were
effective in the solubilised enzyme (data not shown). Evidently, the
Zn2+ site of the reconstituted enzyme is readily accessible to metal
ions in the external solvent. To investigate the metal-ion permeability
of the liposome membrane we used a dye, FluoZin-3, whose
ﬂuorescence is enhanced upon binding to Zn2+ [70]. FluoZin-3 was
trapped inside a liposome preparation, and external dye was then
removed by gel ﬁltration (see Materials and methods). Carbonylcya-
nide-p-triﬂuoromethoxyphenyl hydrazone was added to a dilute
suspension of the liposomes to collapse any metal-ion diffusion po-
tential. The subsequent addition of Zn2+ to the liposome suspension
caused only a small increase in FluoZin-3 ﬂuorescence over a period of
several minutes, showing that the metal ion was unable to cross the
liposome membrane (Fig. 4A). However, subsequent addition of the
ionophore, A23187, led to a rapid change in ﬂuorescence as the
accessibility of the dye to the Zn2+ was increased. In a separate
experiment Zn2+ addition after treatmentwithA23187 led to a prompt
increase in ﬂuorescence (Fig. 4B).
3.5. Changes in the ATR-FTIR spectrum of transhydrogenase resulting
from Zn2+ binding
Using a procedure developed for other membrane proteins [71],
thin ﬁlms of His-tagged transhydrogenase deposited on the surface of
an ATR prism revealed reversible changes in their IR spectrum during
perfusion with nucleotide substrates [57]. There were distinctive
Fig. 4. Liposome permeability to Zn2+. Liposomes (1.0 ml containing 4 mg ml−1 lipid,
see Materials and methods) were added to 2.0 ml of 50 mMHEPES–KOH pH 7.2, 50 mM
KCl and the mixture was supplemented with 5 μM carbonylcyanide-p-triﬂuorometho-
xyphenyl hydrazone. Trace A shows two additions of Zn2+ (both 5 μM), A23187 (13 μM)
and EDTA (400 μM). In Trace B the two additions of Zn2+ were 20 μM. The excitation
wavelength was 495 nm and the emission, 520 nm. Temperature=25 °C.
Fig. 5. The Zn-induced FTIR difference spectrum of wild-type CHT-transhydrogenase,
CHT-βH91K and of poly-L-His. The top spectra are for ﬁlms of wild-type CHT-
transhydrogenase (solid line) and βH91K CHT-transhydrogenase (dotted line). The
perfusion buffer was 50 mMHEPES–KOH pH 7.2, 2 mMMgCl2 with and without 100 μM
Zn2+. The bottom spectrum is for a ﬁlm of poly-L-His. The perfusion buffer was 50 mM
HEPES–KOH pH 7.2, 2mMMgCl2 with andwithout 10 μMZn2+. The difference spectrum
for wild-type protein is an average of 12 buffer cycles, that for the βH91K mutant, 8
cycles, and that for the poly-L-His, 10 cycles. Each buffer cycle comprised 6 min of
perfusion in the absence of Zn2+ followed by 6 min in the presence of Zn2+.
Temperature=25 °C.
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NADP+ or NADPH were used for perfusion. By comparison with the
spectra of model compounds, peaks in these nucleotide-induced
difference spectra were tentatively assigned to groups from either the
protein or the nucleotide. Very similar spectral changeswere observed
during nucleotide perfusion of ﬁlms of CHT-transhydrogenase (data
not shown). NADP+- and NADPH-induced difference spectra recorded
in the presence of 50 μM Zn2+ were similar to those observed in the
absence of the metal ion (data not shown). This is good evidence that
Zn2+ does not directly affect the binding of either NADP+ or NADPH to
the enzyme.
A Zn2+-induced difference spectrum was obtained from data
collected when metal-ion-containing and metal-ion-free buffer were
alternately perfused over a ﬁlm of CHT-transhydrogenase. Changes
produced by the Zn2+were reversible overmany cycles of perfusion; an
averaged difference spectrum is shown in Fig. 5. Zn2+ has no absorption
in the IR and all the features in the spectrum are attributable to changes
in the protein. The conﬁdent assignment of these spectral features will
require further experiments involving H-D exchange, isotopic labelling
of the protein, and site-directed mutagenesis but provisional assign-
ments should help to direct future work. Previous X-ray structures
[37,45,46] and XAFS experiments [48–50] reveal that the Zn2+-binding
sites affecting proton transfer in proteins can involve His residues. Fig. 5
shows a Zn2+-induced “model” difference spectrum of a ﬁlm of poly-
L-histidine. Comparison with the protein spectrum indicates that the
large positive band in the difference spectrum of transhydrogenase at
1117 cm−1 is probably the result of a change in one ormore His residues
caused by Zn2+ binding. Ab initio quantum mechanical calculations on
4-methyl imidazole show that a spectral change in this region of
the spectrum results from the binding of Zn2+ to the NE2 atom [72].
Further comparison of the spectra in Fig. 5 suggests that the troughs at
988 cm−1 and 1088 cm−1, and the peak at 972 cm−1, might also beattributable to changes caused by Zn2+ binding to His residue(s) of
transhydrogenase.
Asp andGlu residues are frequently found in the Zn2+-binding sites
of proteins [73], and there are features in the Zn2+-induced difference
spectrum of transhydrogenase (Fig. 5) that are consistent with the
view that themetal ions do indeed bind to carboxyl group(s). The peak
at 1602 cm−1 and trough at 1556 cm−1may represent the upshift of an
absorbance band at around 1575 cm−1 corresponding to the asym-
metric stretch of COO− [74,75]. Equivalently, the peak at 1418 cm−1
and the trough at 1398 cm−1 may represent the upshift of a band at
around 1400 cm−1 corresponding to the symmetric stretch of COO−.
The peak at 1430 cm−1 could be an indication of this vibrational mode
in another COO− group. The rather broad absorbance decrease in the
Zn2+-induced difference spectrum at 1704 cm−1 might arise from
either a lipid-ester bond [76] or from the vibrationalmode of the C=O
stretch of a (protonated) carboxylic acid group of an Asp or Glu
residue; the intensity decrease would imply the loss of the protonated
form upon binding the metal ion.
The cluster of bands between 1630 to 1690 cm−1 in the difference
spectrum lies within the amide I region, and may possibly represent
structural changes in the peptide backbone of the protein that are
associated with the binding of Zn2+ to transhydrogenase. The changes
are rather small and would arise from just a few amino acid residues.
The dependences of the amplitudes of the 1117 and 1398 cm−1
bands in the transhydrogenase difference spectra on the concentration
of Zn2+ in the perfusion buffer (pH 7.2) are shown in Fig. 6. Within
experimental error the data for both peaks (andothers, not shown) can
be ﬁtted to a single Zn2+-binding isotherm with a Kd≈17 μM.
We attempted to perform similar FTIR experiments with Cu2+ but,
consistent with its tighter binding (see above) and therefore an
expected lower rate of dissociation from the transhydrogenase ﬁlm,
spectral changes induced by this metal ion were very slow to recover
following its removal from the perfusion buffer — too slow to apply
the alternating perfusion procedure which is required to improve
signal quality.
Fig. 6. The Zn2+-concentration dependence of FTIR signals of wild-type CHT-
transhydrogenase and CHT-βH91K. Experiments were performed as described in Fig. 5
but at the Zn2+ concentration shown on the abscissa. ● and ○, wild-type CHT-
transhydrogenase; ▲ and Δ, βH91K CHT enzyme. ● and ▲, IR absorbance changes at
1117–1140 cm−1; ○ and Δ, IR changes at 1398–1420 cm−1.
Fig. 7. The pH dependence of cyclic transhydrogenation by wild-type CHT-transhy-
drogenase and CHT-βH91K. Experiments were carried out in 25mMHEPES, 25mMMES
at the pH indicated on the abscissa. NADH (200 μM), AcPdAD+ (200 μM) and NADP+
(50 μM). ○, wild-type CHT-transhydrogenase (60 pmol protein); ●, βH91K CHT-
transhydrogenase (55 pmol protein). Temperature=25 °C.
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His91 in putative transmembrane-helix 9 in the β subunit of E. coli
transhydrogenase is well conserved across species. An equivalent His
residue is present in 89 of the 111 enzymes listed in [24] but is
replaced by Asn in 22 others. All 22 transhydrogenases with the subs-
titution are in the same clade of the phylogenetic tree (constructed
according to [24]), suggesting that a stable His→Asn mutation at this
position has arisen only once during evolution. This clade is in the 3-
polypeptide group of enzymes, although other clades in the group
(such as that containing R. rubrum transhydrogenase) have the His. In
all 22 of the βHis91→Asn sequences, βSer92 (E. coli numbering) is
replaced by Gly/Ala, and both βVal94 and βSer20 are replaced by Gly
residues. In all but one of the βHis91→Asn sequences, αGln501 is
changed to Asp/Glu/His (the exception, Rubrobacter xylanophilus
transhydrogenase, has an Asn). None of these 4 substitutions is found
in the βHis91 enzymes suggesting that they may help to compensate
for loss of structure/function in the Asn species. A particularly
interesting organism, Colwellia psychrerythraea, has genes for two
transhydrogenases. One is in the 2-polypeptide group with a βHis91
equivalent. The other is in the 3-polypeptide group, and the equivalent
of βHis91 is changed to an Asn; following the usual pattern it has Gly
residues replacing βSer20, βSer92 and βVal94, and His replacing
αGln501.
In Refs [32,35,36] it was found that the rate of reverse transhy-
drogenation in membrane preparations of the βH91K mutant of E. coli
transhydrogenase was greatly inhibited but the cyclic reaction was
stimulated relative to wild-type. On this basis there is a resemblance
between the effect of themutation, and of Zn2+ treatment ofwild-type
transhydrogenase. Hu et al. [34] also observed a strongly inhibited
reverse reaction in their preparations of βH91K but, in marked
contradiction with [32,35,36], they found that the cyclic reaction was
6-fold slower in the mutant than in wild-type, a considerable
discrepancy. To help resolve the discrepancy and to investigate theTable 2
Nucleotide content of wild-type transhydrogenase and the βH91K mutant.
NADP+ NADPH
CHT-wild-type, preparation 1 0.025 0
CHT-wild-type, preparation 2 0.010 0
CHT-wild-type, preparation 3 0.040 0
CHT-βH91K, preparation 1 0.30 0.05
CHT-βH91K, preparation 2 0.20 0.17
See Materials and methods. Values are given as mol nucleotide mol−1 αβ protein
“monomer”.effects of Zn2+ on this mutant we have therefore isolated and puriﬁed
the CTH form of βH91K.
The rate of reverse transhydrogenation in puriﬁed CTH-βH91Kwas
12 and 15 mol AcPdAD+ reduced mol−1 protein min−1 at pH 7.2 in
two independent preparations, ie. ∼1% of that inwild-type. The rate of
the NADP+-supported cylic reaction (563±37 mol AcPdAD+ reduced
mol−1 protein min−1 at pH 7.2 in 4 preparations) was ∼35% higher in
CTH-βH91K than in wild-type CHT protein. These results agree
therefore with those obtained in refs [32,35,36] and disagree with
those obtained in Ref. [34]. Reasons for the eccentric result of [34]
remain unclear.
Also in agreement with [32] the rate of AcPdAD+ reduction by
NADH catalysed by CTH-βH91K transhydrogenase in the absence of
added NADP+ or NADPH was much higher than in wild-type CTH
enzyme (in our experiments about 30-fold at pH 7.2). In membranes
expressing βH91K, there was about 20 timesmore bound NADP+ than
in membranes expressing wild-type enzyme (the NADPH content was
negligible in both) [32,35]. Our experiments with puriﬁed CTH
enzymes yielded equivalent results (Table 2): the βH91K protein
retained much more NADP+ plus NADPH from the host bacterial cell
throughout the puriﬁcation protocol than the wild-type enzyme. Thus
in the mutant, AcPdAD+ reduction by NADH in the absence of added
NADP+ (or NADPH) can probably be attributed to a cyclic reaction
supported by the tightly bound NADP+. Consistent with this, theFig. 8. The effect of Zn2+ on the cyclic reaction catalysed by CHT-βH91K. Experiments
were carried out on the βH91K CHT-transhydrogenase (55 pmol protein) in 1.0 ml
buffer containing 2 mMMgCl2 and 0.03% Anapoe35 at the Zn2+ concentration shown on
the abscissa. The buffer was 50 mM MES–KOH, pH 6.2 (●), 50 mM HEPES–KOH, pH 7.2
(○) or 50 mM HEPES–KOH, pH 8.2 (▲). Temperature=25 °C.
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addition of either NADP+ or NADPH in CTH-βH91K at pH 7.0 com-
pared with ∼25 fold in the wild-type CTH enzyme.
In contrast with the bell-shaped pH dependence of reverse trans-
hydrogenation in wild-type transhydrogenase [54], the very low rate
of the reverse reaction in CTH-βH91K was only weakly affected by pH
in the range 5.5 to 8.3 (data not shown). The pH dependence of the
cyclic reaction in CTH-βH91K was broadly similar to that of wild-type
enzyme but the characteristic increase at low pH [54] was less
pronounced (Fig. 7, and see also the experiments of [34,35]). The
diverging pH dependences resulted in a slight inhibition of the rate of
the cyclic reaction at pH 6.0. Also in contrast to wild-type protein,
there was no lag at the onset of NADP+-dependent cyclic transhy-
drogenation in CTH-βH91K at pH 6.2, 7.2 or 8.2 (Fig. 3G, performed at
pH 7.2) — again this observation parallels that seen with wild-type
enzyme treated with Zn2+.
The similarity between the properties of the wild-type protein
treatedwith Zn2+ and CTH-βH91K suggest that themetal-ion-binding
site and the mutation might be at the same locus. Consistent with this
the effect of Zn2+ on the mutant protein was much less pronounced,
although there was still some sensitivity to metal ions. Thus, ∼75 μM
Zn2+ half-inhibited the very low (∼1%) residual rate of reverse
transhydrogenation in CTH-βH91K at pH 7.2 (compared with 7 μM
Zn2+ in wild-type CTH enzyme) — data not shown. Furthermore,
addition of Zn2+ to the mutant stimulated the reduction of AcPdAD+
by NADH in the presence and in the absence of NADP+ (Fig. 8) but the
degree of stimulation was substantially less than that observed with
wild-type enzyme (2-fold compared with 4-fold at pH 7.2), and a
higher concentration of metal ions was required (38 μM compared
with 18 μM for half-maximal effect).
Perfusion of CTH-βH91K ﬁlms with 100 μM Zn2+ led to the FTIR
difference spectrum shown in Fig. 5. As in the wild-type, the mutant
difference spectrum revealed probable contributions from His and
carboxylate residues but the amplitudes were lower: by a factor of
about 0.5 for the putative His signal at 1117 cm−1 and about 0.3 for the
putative COO− signal at 1398 cm−1. Within experimental error the
dependence of signal amplitude on the Zn2+ concentration perfused
over the mutant ﬁlmwas similar to that for wild-type protein (Fig. 6).
4. Discussion
The use of a His tag greatly improves the yield and quality of
transhydrogenase preparations [23,57]. However, the tag binds metal
ions such as Zn2+ and leads to effects on enzyme activity that are not
observed in the untagged protein. This precludes an investigation into
the speciﬁc effects of metal ions on proton transfer and coupled
NADP(H) binding and release in tagged transhydrogenase. The cons-
truction of an E. coli transhydrogenase with a cleavable His tag has
allowed us to circumvent the problem, and prepare good quality
detergent-dispersed enzyme with properties resembling those of the
membrane-bound untagged form.
4.1. Inhibition of forward and reverse transhydrogenation,
and stimulation of cyclic transhydrogenation, by low pH, Zn2+
and by the βH91K substitution
The minimal model for the mechanism of action of transhydro-
genase, shown in Fig. 1, is well supported by experiment [18,31,54,
55,62,65,77] and provides a good framework for understanding the
observations described in this paper. The enzyme has an “open” state
(E and E⁎) and an “occluded” state (E⁎⁎). Interconversion of E⁎ and
E⁎⁎ (steps b and e) is coupled to H+ translocation through the dII
proton motor. NADP+ and NADPH bound to E⁎⁎ (but not NADP+ and
NADPH bound to E⁎) can participate in a redox reaction with either
NAD(H) (step c) or AcPdAD(H) (step d). E⁎ (but not E⁎⁎) can
exchange its bound NADP(H) with nucleotide in the solvent (steps aand f). The proton motor can bind H+ from the p-phase in E⁎.NADP+
(step b), and H+ from the n-phase in E⁎.NADPH (step e). For further
discussion see [25,26,78,79]. In the following paragraphs it is argued
that low pH, the binding of metal ions such as Zn2+, and the βH91K
substitution, all cause the enzyme to “lock” into the occluded state;
that is, these perturbations effectively decrease the rate constant for
the conversion of E⁎⁎ into E⁎ at steps b and e.
Each of the three kinds of perturbation results in a similar set of
experimental ﬁndings: the inhibition of reverse and forward transhy-
drogenation, the stimulation of cyclic transhydrogenation and the
elimination of the lag at the onset of the NADP+-dependent cyclic
reaction. It may be seen from Fig. 1 that restricted conversion of E⁎⁎.
NADPH into E⁎.NADPH (at step e) limits the rate of forward transhy-
drogenation, that restricted conversion of E⁎⁎.NADP+ into E⁎.NADP+
(at step b) limits the rate of reverse transhydrogenation and that, as a
consequence of these restrictions, the elevated populations of E⁎⁎.
NADPH and E⁎⁎.NADP+ sustain a higher rate of the cyclic reactions.
The lag in the NADP+-dependent cyclic reaction at pH 7.2 (Fig. 3A and
C) is the result of only gradual accumulation of product NADPH in the
solvent from coincident forward transhydrogenation: because steps e
and f are coupled equilibria, the accumulating NADPH favours an
increase in the population of E⁎⁎.NADPH and this accelerates the
cyclic reaction. A decrease the rate of conversion of E⁎⁎.NADPH→E⁎.
NADPH (by low pH, Zn2+ binding, and in βH91K) results in
elimination of the lag (Fig. 3E, F and G). There is no lag in AcPdAD+
reduction by the combination of NADPH and NADH because the
contribution from the reverse reaction leads to direct formation of
AcPdADH.
A simple kinetic model based on Fig. 1 shows how locking the
enzyme in the occluded forms modiﬁes the steady-state rates of
forward, reverse and cyclic transhydrogenation. In Fig. 9 the model is
set up to show the effects of Zn2+ on the transhydrogenation reaction
rates but an equivalent form equally well describes the effects of low
pH and of the βH91K mutation. Fig. 10 shows that the model
successfully reproduces the complex, experimentally-observed pat-
tern of Zn2+ inhibition of forwardand reverse transhydrogenation, and
Zn2+ stimulation of the NADP+-dependent cyclic reaction (Fig. 2), by
changing only two rate constants; k4 and k7 (governing the E⁎⁎→E⁎
steps) are increased 100-fold to k4Zn and k7Zn. Binding constants for
NADP(H) and Zn2+ match experimental values but other rate
constants are chosen arbitrarily to approximately ﬁt the reaction
rates observed in Fig. 2.
The effect of low pH on steps b and e can be simply explained since
protons participate directly in these reactions: dissociation of H+ into
the p-phase at step b, and into the n-phase at step e, are suppressed as
the solution pH is lowered ([H+p] and [H+n] are, of course, identical in
the solubilised enzyme). In themodel, the protonation/deprotonation
reactions at b and e are essential components in the process of proton
translocation by transhydrogenase. Thus at higher pH, dissociation of
H+ becomes favourable and, following hydride transfer, the enzyme
returns to the open state from which NADP(H) can be released to
enable complete turnover. Two observations indicate that the effects
of low pH and of Zn2+ treatment are not additive, suggesting that H+
and metal-ion binding affect the E⁎↔E⁎⁎ step in a related way (see
Fig. 2). First, at pH 6.2, where the cyclic reaction is close-to maximal,
there is no further stimulation of the rate by Zn2+. Second, at pH 7.2
and 8.2 the addition of Zn2+ increases the cyclic reaction to a rate
approaching but not exceeding that observed at low pH in the absence
of metal ions. The experiments with reconstituted transhydrogenase
indicate that the metal-ion binding site is located on the n-side of the
membrane, the side from where the dI and dIII components emanate
from dII, and from where protons are released during forward
transhydrogenation. It is proposed that the metal ions bind into the
n-side proton channel close to the proton motor and (like protons)
drive formation of the occluded state; it might be the positive charge
introduced by the metal ion (or the proton) that effects the confor-
Fig. 9. Akineticmodel to explain the effects of Zn2+on transhydrogenase reactions. Based on the scheme in Fig.1. Rate constants for the binding and release of NADP+ andNADPH(k1, k2, k9
and k10) giveKd values in the sameorder as experimental values [57,90]. The interconversion of E⁎ and E⁎⁎ is complex (see text); it is not described explicitly in themodel but is represented
(k3, k4, k7 and k8) by arbitrary, ﬁrst-order rate constants. The step described by k5 subsumes NADH binding, hydride transfer from bound NADH to bound NADP+ and release of NAD+;
because in experiments the initial concentration of NADH is high and that of NAD+ is zero, k5 is taken as an arbitrary, ﬁrst-order rate constant. The step described by k6 subsumesAcPdAD+
binding, hydride transfer from bound NADPH to bound AcPdAD+ and AcPdADH release; for similar reasoning to the above k6 is also taken as an arbitrary ﬁrst-order rate constant.
Zn2+ binds to all intermediates shown in themodelwith the same afﬁnity; rate constants for binding and release of themetal ions give aKd in the same order as the experimentalK0.5 (see
Table 1). Zn2+binding decreases k4 (to k4Zn) and k7 (to k7Zn) by a factor of 100. Themetal ions have no direct effect on the binding and release of nucleotides, or onhydride transfer: the rate
constants for these reaction steps involving intermediates with bound Zn2+ are identical to those with no bound Zn2+.
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Zn2+ is not translocated across the membrane-spanning dII.
Zn2+ (as well as Cd2+ and Cu2+) more potently inhibited reverse
transhydrogenation at high than at low pH — see Results (other ionsFig. 10. Steady-state rates of cyclic (●), forward (▼) and reverse (○) transhydrogena-
tion at different concentrations of Zn2+ calculated from the model described in
Fig. 9. For the cyclic reaction the following rate constants were assigned: k1=1010 M−1
s−1, k2=105 s−1, k3=10 s−1, k4=50 s−1, k4Zn=0.5 s−1, k5=60 s−1, k6=60 s−1,
k7=10 s− 1, k7Zn=0.1 s− 1, k8=50 s− 1, k9=105 s− 1, k10=1010 M− 1 s− 1,
k11=1010 M−1 s−1, k12=5×104 s−1; the initial concentration of E=1×10−8 M
(that of all other enzyme forms=0), the initial concentration of NADP+=10−4 M and
that of NADPH=0. For the forward reaction, the rate constants and initial concentra-
tions were similar to those used for cyclic except that k6=0 (since AcPdAD+ is omitted
from the assays). For the reverse reaction, the rate constants and initial concentrations
were similar to those used for cyclic except that k5=0 (since NADH is omitted from the
assays), the initial concentration of NADP+=0 and that of NADPH=10−4 M.
Calculations were performed using the program, GEPASI [91]. In all the simulated
reactions, steady-state rates were reached in b1 s, and remained constant for N60 s.were not tested in this regard). This suggests competition between H+
and the metal ions, and can be explained by the model. During reverse
transhydrogenation protons must bind from the n-side of the enzyme
to drive the conversion of E⁎.NADPH to E⁎⁎.NADPH in step e. Following
hydride transfer to AcPdAD+ at step d, the enzyme reverts to the open
state as protons are released to the p-side (step b). However, metal
ions binding to the n-side site (in competition with protons) lock the
enzyme in the E⁎⁎ form but are not translocated, and therefore cause
inhibition.
In the current experiments the effect of the βH91Kmutation in the
puriﬁed CHT enzyme reproducibly led at neutral pH to inhibition of
reverse transhydrogenation and to stimulation of the cyclic reaction.
This conﬁrmed some earlier experiments on membrane vesicles
[32,35,36] but disagreed with others [34]. As indicated above, our
ﬁndings on the reaction kinetics are explained by the notion that the
mutation locks transhydrogenase in the E⁎⁎ state. It is signiﬁcant that
CHT-βH91K retained approximately 0.4mol (NADP+ plus NADPH) per
mol protein monomer during puriﬁcation, whereas the wild-type
enzyme retained very little (Table 2, and see [32]). This strongly
supports the suggestion that the mutant is locked in the occluded
state and cannot readily release its bound NADP+ and NADPH. It also
explains why reduction of AcPdAD+ by NADH in puriﬁed βH91K
proceeds rapidly even without added NADP+ or NADPH: the tightly
bound nucleotide in E⁎⁎.NADP(H) is alternately reduced by NADH and
oxidised by AcPdAD+ in a standard cyclic reaction. This view is further
strengthened by the ﬁnding that addition of extra NADP+ or NADPH
leads to only a small rate increase.
Predictive algorithms place βHis91 in transmembrane-helix 9,
deep in the membrane but towards the cytoplasmic side (eg [23]).
Extending the suggestions of others [30–36], we propose that this
residue is located in or near the n-side proton channel leading to the
proton motor, and that the positive charge introduced by the βH91K
mutation (analogous to protonation or Zn2+ binding) is responsible
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enzyme in the E⁎⁎ forms. As expected from our hypothesis, the
stimulatory effect of Zn2+ and of low pH on cyclic transhydrogenation
are considerably diminished in the βH91K mutant. However, there is
still some effect of the metal ion (eg Fig. 8) and of low pH (Fig. 7). The
E⁎↔E⁎⁎ step, of course, comprises more than one reaction, including
the transmission of H+ along the respective half-channel, protona-
tion/deprotonation of groups in the proton motor, and consequent
initiation of conformational changes that enable/disable hydride
transfer. The effects of Zn2+ and H+ binding, and of the βHis91→Lys
substitution, probably do not precisely overlap. For example, the
amino acid substitution might cause a block at an early stage in the
conversion of E⁎→E⁎⁎ (late in the conversion of E⁎⁎→E⁎). This
would still permit limited equilibration into intermediates that do not
participate in cyclic transhydrogenation; it would stimulate the cycle
but would not lead to full expression of the maximum rate. Zn2+ or
low pH would further increase the rate in βH91K by conﬁning the
enzyme to those intermediates that do directly participate in cyclic
transhydrogenation.
4.2. Other mutations also lock transhydrogenase in the occluded state
Single-site substitutions of βHis91 with other than the Lys residue
also result in changes in transhydrogenase properties [30–36]. Many
mutants (βH91A, C, D, E, G, I, L, M, R, S, T, V, W and Y) – expressed in E.
coli membranes – have inhibited rates of both reverse and cyclic
transhydrogenation but there may be a variety of reasons for this
behaviour. In βH91N reverse transhydrogenation is only partially
compromised but associated proton translocation is strongly inhibited,
and it was argued that the redox reaction is decoupled from proton
pumping in this mutant [31,33,36]; in the context of our model the E⁎
and E⁎⁎ forms of βH91N would interconvert without accompanying
protonation/deprotonation.
The phenotype in which reverse and forward transhydrogenation
are inhibited but the cyclic reaction is either less inhibited or
stimulated, is not only found in the βH91K mutant. There are
indications from studies with E. coli membranes that some amino
acid substitutions of αHis450 [33], βAsn222 [35] and βMet257 [80] in
dII fall into this category, as perhaps does the “αQRML-deletion”
mutant [32]. Interestingly, the Q in this deletion is Gln501 – the
residue which is replaced by Asp, Glu or His in all but one species
with Gln at the equivalent of βHis91 – see Results. In βAsn222
mutants, and the αQRML-deletion mutant, assays revealed tightly
bound NADP(H) associated with the membranes. Perhaps more
convincingly, experiments with pure preparations of several βGly252
mutants revealed that all had tightly bound NADP(H), and all
catalysed a high rate of AcPdAD+ reduction by NADH in the absence
of added NADP(H) [81]. By the criteria outlined above, all these
mutants would appear to be locked in the E⁎⁎ state. Some of the
mutated amino acid residues are located in predicted transmembrane
regions of dII (generally closer to the n-side of the membrane), and
some are in n-side loops between transmembrane helices. The
functional similarities suggest that all these amino acid residues
might be located in the n-side channel of the proton motor. The
different mutants could be compromised at different intermediates in
the E⁎↔E⁎⁎ transition and studies on the effects of Zn2+ in the
mutants should help resolve this issue.
It is also signiﬁcant that the isolated dI2dIII1 complex behaves as
though it is locked in the occluded state [62,82] — it catalyses very
slow forward and reverse transhydrogenation but a fast cyclic
reaction. Structural features which might be responsible for fast
hydride transfer in the complex [83], and the very slow rate of
exchange of bound NADP(H) with nucleotides in the solvent
[62,84,85], are evident in the X-ray structures (see [21]). As expected,
Zn2+ has no stimulatory effect on the cyclic reaction catalysed by the
dI2dIII1 complex [51].4.3. The character of the Zn2+-binding site(s) in transhydrogenase
The NADP+- and NADPH-induced ATR-FTIR difference spectra of a
CHT-transhydrogenase ﬁlm (see [57]) were unaffected by Zn2+. This
shows that, consistent with the model, the metal ions do not directly
affect nucleotide binding (steps a and f); rather, the Zn2+ affects the
E⁎↔E⁎⁎ reaction (steps b and e).
The perfusion of a CHT-transhydrogenase ﬁlm with Zn2+ led to
distinctive changes in the IR spectrum. The dependence on Zn2+
concentration of the intensity of bands in the difference spectrum
yielded a Kd which was close to the K0.5 determined in solution assays
of Zn2+ inhibition. This suggests that the features observed in the IR
probably relate to the metal-binding site in the n-side proton-transfer
channel. The provisional assignments of bands in the Zn2+-induced
difference spectra (Fig. 5) indicate that His and either Asp or Glu
residues are involved in metal binding. This is consistent with X-ray
structures and XAS experiments in which it was shown that these
amino acid residues also contribute to the inhibitorymetal-ion binding
sites in the proton-transfer pathways of photosynthetic reaction
centres, cytochrome bc1 complex and cytochrome oxidase [37,45,
46,48–50]. However, there is only aweak correspondence between the
potency of metal-ion inhibition of these different membrane proteins,
compare Table 1 with [38,39,42,86]. It is unlikely that the proton-
transfer pathways share a unique structural motif capable of a speciﬁc
type of interaction with the metal ion. Rather, the entrance and exit
sites of proton-transfer pathways at the membrane–water interface
probably quite frequently employ Asp, Glu and His residues, and there
may be sufﬁcient sidechain and backbone ﬂexibility for the carboxyl O
and imidazol N atoms in such amino acid clusters to coordinate with
metal ions in different structural organisations. Indeed X-ray struc-
tures showclear differences in theway that Zn2+, Cd2+, Ni2+ and Co2+
bind in the proton-transfer pathway of reaction centres [37]. The
binding of metal ions to Asp, Glu and His residues on protein surfaces
may be quite common; note, for example, the numerous Zn2+-binding
sites on cytochrome oxidase [45] and the Zn2+-induced ATR-FTIR
difference spectra of cytochrome c [87]. In some circumstances, metal-
ion binding may be innocuous but where the surface residues that
serve as ligands have an essential function, as in the Asp, Glu andHis in
the mouth of an essential proton channel, it is inhibitory.
Relatively high concentrations (N10−3 M) of the “hard”metal ions,
Mg2+ and Ca2+, stimulate reverse and forward transhydrogenation
catalysed by the E. coli enzyme [54,66]. This indicates that they do not
bind into the n-side proton channel and block H+ transfer to the
motor like the softer ions investigated in this report but that theywork
on the enzyme by a quite different mechanism. The potency on
transhydrogenase activity of the ﬁrst row of d-block elements tested
here (Mn2+, Co2+, Ni2+, Cu2+ and Zn2+) approximately follows
atomic number. The trend may suggest that tighter interaction with
the binding site is a result of decreased ionic radius, increased electron
afﬁnity and increased crystal-ﬁeld stabilisation energy (and see [43]).
Cu2+ deviates from the trend, perhaps because its complexes are often
subjected to a Jahn-Teller effect which give them extra stability [88].
Cd2+ is a softer ion than Zn2+, and is more often found in octahedral
as opposed to tetrahedral complexes, but the two ions are effective on
transhydrogenase in the same concentration range. A similar ﬁnding
was reported for photosynthetic reaction centres [38,86]. The high
potency of Pb2+ (a p-block metal ion) on the transhydrogenase reac-
tions can probably be explained because (like Zn2+, Cu2+ and Ni2+) it
is of borderline hardness and because its complexes span a range of
coordination numbers (3–8) with different, often distorted, geome-
tries: it can readily adapt to the binding site in the protein [88,89].
In βH91K the amplitudes of signals in the Zn2+-induced FTIR
difference spectrum that are attributable to His and carboxyl residues
are attenuated by 30–50% relative to wild-type. This suggests that a
metal-ion binding site (or sites) partly constructed from these
residues is either lost or modiﬁed in the mutant; it is suggested that
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amongst the ligands responsible for the binding of Zn2+ in the site.
Taken together with the effect of the βHis91→Lys substitution on the
enzyme kinetics, it is consistent with the view that βHis91, and the
Zn2+-sensitive site, have a role in proton transfer associated with inter
conversion of the E⁎ and E⁎⁎ states of transhydrogenase. The signals
provisionally assigned to His and carboxyl residues in the Zn2+-
induced FTIR difference spectrum of the βH91K mutant might arise
from another site in the proton-translocation pathway. There are
numerous Asp, Glu and other His residues in dII which might con-
tribute to such a site. However, it cannot be ruled out that the site seen
in the βH91K spectrum is due to adventitious Zn2+ binding and is not
a proton-transfer site.
In conclusion it has been shown that Zn2+ and other metal ions are
useful probes for investigating the mechanism of action of transhy-
drogenase. Further progress will probably depend on the emergence
of a high-resolution structure of the enzyme which, to date, has
evaded attempts in several laboratories. The protein conformation
around the Zn2+-binding site should be particularly informative about
the mechanism of proton translocation and how this is coupled to the
redox reaction between the bound nucleotides.
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